Related Experiment Videos
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?
1Cambridge Centre for Brain Repair, University of Cambridge, UK. ker28@hermes.cam.ac.uk
Abstract:
It is well established that axonal regeneration in the adult CNS is largely unsuccessful. Numerous axon-inhibitory molecules are now known to be present in the injured CNS, and various strategies for overcoming these obstacles and enhancing CNS regeneration have been experimentally developed. Recently, the use of chondroitinase-ABC to treat models of CNS injury in vivo has proven to be highly beneficial towards regenerating axons, by degrading the axon-inhibitory chondroitin sulphate glycosaminoglycan chains found on many proteoglycans in the astroglial scar. This enzyme has now been shown to restore synaptic plasticity in the visual cortex of adult rats by disrupting perineuronal nets, which contain high levels of chondroitin sulphate proteoglycans (CS-PGs) and are expressed postnatally around groups of certain neurons in the normal CNS. The findings suggest exciting prospects for enhancing growth and plasticity in the adult CNS; however, some protective roles of CS-PGs in the CNS have also been demonstrated. Clearly many questions concerning the mechanisms regulating expression of extracellular matrix molecules in CNS pathology remain to be answered.
Insights
Chondroitinase-ABC enzyme aids axonal regeneration in the central nervous system (CNS) by degrading inhibitory molecules. This promotes synaptic plasticity, offering new hope for CNS repair after injury.
Area of Science:
- Neuroscience
- Biochemistry
Background:
- Axonal regeneration in the adult central nervous system (CNS) is significantly limited.
- The injured CNS contains molecules that inhibit axon growth.
- Strategies to overcome these inhibitory factors are under investigation.
Purpose of the Study:
- To investigate the efficacy of chondroitinase-ABC in promoting axonal regeneration and synaptic plasticity.
- To explore the role of chondroitin sulphate proteoglycans (CS-PGs) and perineuronal nets in CNS repair.
Main Methods:
- Administration of chondroitinase-ABC in vivo to models of CNS injury.
- Degradation of chondroitin sulphate glycosaminoglycan chains in the astroglial scar.
- Assessment of synaptic plasticity restoration in the visual cortex of adult rats.
Main Results:
- Chondroitinase-ABC treatment demonstrated significant benefits in regenerating axons after CNS injury.
- The enzyme disrupted perineuronal nets, restoring synaptic plasticity in the visual cortex.
- Chondroitin sulphate proteoglycans (CS-PGs) were identified as key inhibitory components.
Conclusions:
- Chondroitinase-ABC is a promising therapeutic agent for enhancing axonal growth and plasticity in the adult CNS.
- Targeting CS-PGs offers a viable strategy for CNS regeneration.
- Further research is needed to fully understand the regulatory mechanisms of extracellular matrix molecules in CNS pathology.